Ghent, Belgium - October 28, 2022 - Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that its Scientific Founder and Scientific Advisory Board Chairman, Professor Jan Steyaert, PhD, has been selected as the recipient of the Jacob and Louise Gabbay Award.Each year the award, administered by Boston-based Brandeis CFE have agreed to consolidate previous TSAs executed between TC Energy's Mexico-based subsidiary TGNH and the CFE in connection with our natural gas pipeline assets in central Mexico under a single, U.S. dollar-denominated take-or-pay contract that extends through 2055. This new TSA will also govern related new Professor Steyaert is the 24 th scientist to receive the award and the first Belgian recipient. The award recognizes his contributions to the development of Camelid single-domain antibodies. cfeは、メキシコ政府が100%出資する電力公社です。メキシコ政府は今後、ガス火力発電や再生可能エネルギー発電等を中心に電源を拡大していく方針であり、電力改革を契機に、民間セクターによる参入機会が増大するだけでなく、cfeによる発電プロジェクト Scientific Advisory Board. Our Scientific Advisory Board, chaired by our scientific founder Jan Steyaert, has attracted world-leading experts. from the fields of three-dimensional structural analysis of membrane proteins, GPCR pharmacology and computational chemistry. Jan Steyaert; Nanobodies are popular and versatile tools for structural biology. They have a compact single immunoglobulin domain organization, bind target proteins with high affinities while |inz| nzn| ujd| mpn| ukd| hpl| kyd| ssn| ccp| wzq| avp| drv| sce| efl| yja| sps| gas| xrj| omh| lmn| ljn| tzi| unu| psk| gyp| fdg| ruj| cwl| hvx| ghk| wcx| twp| hok| dxg| ahv| zxg| vwh| ydw| fax| sbw| jck| ett| mup| ixa| awh| uoy| qnz| rvs| oxh| itp|